US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gain Therapeutics, Inc.

2.06

-0.1200-5.50%

Post-market: 2.140.0800+3.88%18:34 EDT

Volume:397.65K

Turnover:843.42K

Market Cap:57.24M

PE:-2.31

High:2.27

Open:2.25

Low:2.03

Close:2.18

Loading ...

Overview Company News Filings

Gain Therapeutics Advances GT-02287 in Parkinson’s Trials

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

THOMSON REUTERS

Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update

Gain Therapeutics To Participate in Upcoming Investor Conferences

All You Need to Know About Gain Therapeutics (GANX) Rating Upgrade to Strong Buy

BRIEF-Gain Therapeutics Forms Clinical Advisory Board To Support Continued Advancement Of Lead Drug Candidate GT-02287

Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

THOMSON REUTERS

Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

Gain Therapeutics Appoints New CEO Amidst Clinical Progress

Gain Therapeutics appoints Mack as CEO, Director

Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director

THOMSON REUTERS

Press Release: Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director

Gain Therapeutics’ GT-02287 study to deliver positive findings, says Roth MKM

Gain Therapeutics Says Australia Approves Start of Phase 1b Parkinson's Disease Study

MT Newswires Live

Gain Therapeutics initiates Phase 1b trial of GT-02287

Gain Therapeutics Inc - Enrollment Expected to Complete in Spring 2025, Data Expected Mid-2025

THOMSON REUTERS

Gain Therapeutics Initiates Phase 1B Clinical Trial of Lead Candidate GT-02287 in People With Gba1 and Idiopathic Parkinson’s Disease

THOMSON REUTERS

Gain Therapeutics Initiates Phase 1b Clinical Trial of Lead Candidate GT-02287 in People with GBA1 and Idiopathic Parkinson’s Disease

Gain Therapeutics To Present At Biotech Showcase 2025

Gain Therapeutics Initiated at Buy by Roth MKM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GANX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GANX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GANX\",,,,,undefined,":{"symbol":"GANX","market":"US","secType":"STK","nameCN":"Gain Therapeutics, Inc.","latestPrice":2.06,"timestamp":1746216000000,"preClose":2.18,"halted":0,"volume":397650,"hourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.06,"latestTime":"18:34 EDT","volume":151,"amount":314.17579440000003,"timestamp":1746225283126},"delay":0,"floatShares":26450002,"shares":27786952,"eps":-0.892042,"marketStatus":"Post-Mkt","change":-0.12,"latestTime":"05-02 18:47:16 EDT","open":2.25,"high":2.27,"low":2.03,"amount":843424.00065,"amplitude":0.110092,"askPrice":2.37,"askSize":100,"bidPrice":1.97,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-0.892042,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"adr":0,"listingDate":1616040000000,"exchange":"NASDAQ","adjPreClose":2.18,"preHourTrading":{"tag":"盘前","latestPrice":2.28,"preClose":2.18,"latestTime":"09:27 EDT","volume":3475,"amount":7729.7611575,"timestamp":1746192460030},"postHourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.06,"latestTime":"18:34 EDT","volume":151,"amount":314.17579440000003,"timestamp":1746225283126},"volumeRatio":0.786373,"impliedVol":0.5557,"impliedVolPercentile":0.364},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GANX\",,,,,undefined,":{"symbol":"GANX","floatShares":26450002,"roa":"-82.80%","roe":"-204.95%","lyrEps":-0.892042,"volumeRatio":0.786373,"shares":27786952,"dividePrice":0,"high":2.27,"amplitude":0.110092,"preClose":2.18,"low":2.03,"week52Low":0.89,"pbRate":"7.80","week52High":3.19,"institutionHeld":0,"latestPrice":2.06,"committee":-0.428571,"eps":-0.892042,"divideRate":0,"volume":397650,"delay":0,"ttmEps":-0.892042,"open":2.25,"prevYearClose":2.16,"prevWeekClose":1.895,"prevMonthClose":2.05,"prevQuarterClose":1.91,"fiveDayClose":1.895,"twentyDayClose":1.79,"sixtyDayClose":2.44},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GANX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509780944","title":"Gain Therapeutics Advances GT-02287 in Parkinson’s Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2509780944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509780944?lang=en_us&edition=fundamental","pubTime":"2025-02-07 06:22","pubTimestamp":1738880564,"startTime":"0","endTime":"0","summary":"Gain Therapeutics ( ($GANX) ) has shared an announcement. On February 6, 2025, Gain Therapeutics announced the advancement of their clinical develo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gain-therapeutics-advances-gt-02287-in-parkinsons-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gain-therapeutics-advances-gt-02287-in-parkinsons-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","GANX","BK4119","GT","BK4585","BK4588"],"gpt_icon":0},{"id":"2509276495","title":"Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2509276495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509276495?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:45","pubTimestamp":1738849500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUABWCLWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2509927649","title":"Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2509927649","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509927649?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:45","pubTimestamp":1738849500,"startTime":"0","endTime":"0","summary":"BETHESDA, Md., Feb. 06, 2025  -- Gain Therapeutics, Inc.  , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today provided the following letter to shareholders from the Company’s President and CEO, Gene Mack:. We will also continue building upon the already extensive preclinical dossier for GT-02287 under the leadership of Joanne Taylor, Senior VP of Research, and Terenzio Ignoni, Senior VP of Technical Operations. Together, they will look to further characterize GT-02287’s mechanism of action and elucidate the broader neuroprotective role of GCase, suggested by the work of their respective teams, that goes beyond the lysosome to other cellular compartments including the endoplasmic reticulum and mitochondria. We have observed the stabilization of the mitochondria associated with administration of GT-02287 and its allosteric modulation","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gain-therapeutics-ceo-gene-mack-134500386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1169590202.USD","BK4023","GANX","BK4588","LU1169589451.USD","GT","BK4119","BK4585","LENZ","PD"],"gpt_icon":0},{"id":"2509111286","title":"Gain Therapeutics To Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2509111286","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509111286?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:30","pubTimestamp":1738762200,"startTime":"0","endTime":"0","summary":"BETHESDA, Md., Feb.  05, 2025  (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/05/3021188/0/en/Gain-Therapeutics-To-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GANX","LENZ"],"gpt_icon":0},{"id":"2504945830","title":"All You Need to Know About Gain Therapeutics (GANX) Rating Upgrade to Strong Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2504945830","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504945830?lang=en_us&edition=fundamental","pubTime":"2025-01-17 01:00","pubTimestamp":1737046810,"startTime":"0","endTime":"0","summary":"Investors might want to bet on Gain Therapeutics, Inc. , as it has been recently upgraded to a Zacks Rank #1 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.As such, the Zacks rating upgrade for Gain Therapeutics is essentially a positive comment on its earnings outlook that could have a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/know-gain-therapeutics-ganx-rating-170010869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GANX"],"gpt_icon":0},{"id":"2501172726","title":"BRIEF-Gain Therapeutics Forms Clinical Advisory Board To Support Continued Advancement Of Lead Drug Candidate GT-02287","url":"https://stock-news.laohu8.com/highlight/detail?id=2501172726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501172726?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:55","pubTimestamp":1736344544,"startTime":"0","endTime":"0","summary":"BRIEF-Gain Therapeutics Forms Clinical Advisory Board To Support Continued Advancement Of Lead Drug Candidate GT-02287Jan 8  - Gain Therapeutics Inc GANX.O:GAIN THERAPEUTICS ANNOUNCES FORMATION OF CLINICAL ADVISORY BOARD TO SUPPORT CONTINUED ADVANCEMENT OF LEAD DRUG CANDIDATE GT-02287Source text: nGNX3X5ZbfFurther company coverage: GANX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA1GXWFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2501219817","title":"Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287","url":"https://stock-news.laohu8.com/highlight/detail?id=2501219817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501219817?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA1GXWFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2501272170","title":"Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287","url":"https://stock-news.laohu8.com/highlight/detail?id=2501272170","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501272170?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341200,"startTime":"0","endTime":"0","summary":"BETHESDA, Md., Jan. 08, 2025  -- Gain Therapeutics, Inc.  , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced the formation of its Clinical Advisory Board  to support the continued development of the Company’s lead drug candidate, GT-02287, in Parkinson’s disease. The CAB is composed of leading experts in Parkinson’s disease trial design, genetics, and biomarkers and will work closely with Gain leadership to progress GT-02287 through potential Phase 2 and Phase 3 clinical development.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gain-therapeutics-announces-formation-clinical-130000745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","NCI","GT","BK4023","BK4588","BK4139","GANX","LENZ","LU1169590202.USD","PD","BK4119","LU1169589451.USD","CAB","BK4202"],"gpt_icon":0},{"id":"2501593877","title":"Gain Therapeutics Appoints New CEO Amidst Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2501593877","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501593877?lang=en_us&edition=fundamental","pubTime":"2025-01-08 06:27","pubTimestamp":1736288868,"startTime":"0","endTime":"0","summary":"Gain Therapeutics ( ($GANX) ) has issued an update. Gain Therapeutics has appointed Gene Mack as its new Chief Executive Officer and Director, effe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gain-therapeutics-appoints-new-ceo-amidst-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gain-therapeutics-appoints-new-ceo-amidst-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GANX","LU2065732104.USD","BK4139","BK4097","PRGS","LENZ"],"gpt_icon":0},{"id":"2501520887","title":"Gain Therapeutics appoints Mack as CEO, Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2501520887","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501520887?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:10","pubTimestamp":1736251834,"startTime":"0","endTime":"0","summary":"Gain Therapeutics (GANX) announced that Gene Mack, who has served as the Company’s Chief Financial Officer since April 2024 and interim Chief Execu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-appoints-mack-as-ceo-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-appoints-mack-as-ceo-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GANX","LENZ"],"gpt_icon":0},{"id":"2501270563","title":"Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2501270563","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501270563?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUABZVDR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2501827032","title":"Press Release: Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2501827032","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501827032?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251200,"startTime":"0","endTime":"0","summary":"Gene Mack Has Served As CFO Since April 2024 And Interim CEO Since June 2024. Gianluca Fuggetta Will Assume The Role Of Senior Vice President, Finance. Gene Mack, newly appointed CEO of Gain, added, \"I am honored by the opportunity to lead the passionate team we have here at Gain -- a team that I have grown very fond of after experiencing firsthand during 2024 how uniformly committed everyone is to our mission of developing truly disease-altering treatments that go beyond temporary symptom relief. I look forward to providing continuing support and contributing to the impressive work being done by my colleagues at Gain as we guide our lead candidate, GT-02287, through the currently ongoing Phase 1b trial in people with Parkinson's Disease during the first half of 2025, while also preparing for potential Phase 2 activities during the second half of 2025.\". Gene has over 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4023","BK4555","BK4585","BK4119","LENZ","GANX","MSD","03160","BK4139","GT","LU1169589451.USD","LU1169590202.USD","PD","BK4588","TM"],"gpt_icon":0},{"id":"2493083215","title":"Gain Therapeutics’ GT-02287 study to deliver positive findings, says Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2493083215","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493083215?lang=en_us&edition=fundamental","pubTime":"2024-12-24 20:40","pubTimestamp":1735044007,"startTime":"0","endTime":"0","summary":"Roth MKM keeps a Buy rating and $7 price target on Gain Therapeutics (GANX) after the company received approval from Australian regulators to begin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-gt-02287-study-to-deliver-positive-findings-says-roth-mkm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-gt-02287-study-to-deliver-positive-findings-says-roth-mkm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4585","BK4119","GT","BK4588","GANX"],"gpt_icon":0},{"id":"2493768493","title":"Gain Therapeutics Says Australia Approves Start of Phase 1b Parkinson's Disease Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2493768493","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493768493?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:00","pubTimestamp":1734962428,"startTime":"0","endTime":"0","summary":"Gain Therapeutics  said Monday it has received approval in Australia to start a phase 1b trial of GT-02287, the company's lead allosteric small molecule in clinical development to treat Parkinson's disease with or without a GBA1 mutation.The main objective of the phase 1b trial is to evaluate the safety and tolerability of GT-02287 and follows the completed phase 1 study in healthy volunteers that showed it was safe, well-tolerated and increased glucocerebrosidase activity, the company said.The company said it expects to complete enrollment for the phase 1b study to be completed in the spring of 2025 and data to be released in the middle of that year.Shares of Gain Therapeutics were up 17% in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","XAO.AU","XJO.AU","GANX","XKO.AU","BK4139"],"gpt_icon":0},{"id":"2493825754","title":"Gain Therapeutics initiates Phase 1b trial of GT-02287","url":"https://stock-news.laohu8.com/highlight/detail?id=2493825754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493825754?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:40","pubTimestamp":1734957623,"startTime":"0","endTime":"0","summary":"Gain Therapeutics (GANX) announced it has received approval in Australia to initiate a Phase 1b trial. Gain will be working with local Parkinson’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-initiates-phase-1b-trial-of-gt-02287?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-initiates-phase-1b-trial-of-gt-02287?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4585","GANX","GT","BK4588","BK4119","BK4139"],"gpt_icon":0},{"id":"2493751603","title":"Gain Therapeutics Inc - Enrollment Expected to Complete in Spring 2025, Data Expected Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2493751603","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493751603?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:30","pubTimestamp":1734957000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA4F5NCG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2493375198","title":"Gain Therapeutics Initiates Phase 1B Clinical Trial of Lead Candidate GT-02287 in People With Gba1 and Idiopathic Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2493375198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493375198?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:30","pubTimestamp":1734957000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA4F5NCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GANX","BK4139"],"gpt_icon":0},{"id":"2493751466","title":"Gain Therapeutics Initiates Phase 1b Clinical Trial of Lead Candidate GT-02287 in People with GBA1 and Idiopathic Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2493751466","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493751466?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:30","pubTimestamp":1734957000,"startTime":"0","endTime":"0","summary":"The Company has received approval to begin enrollment of the Phase 1b clinical trial in Australia Phase 1b clinical trial will assess safety and tolerability along with biomarkers during three months ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/23/3001167/0/en/Gain-Therapeutics-Initiates-Phase-1b-Clinical-Trial-of-Lead-Candidate-GT-02287-in-People-with-GBA1-and-Idiopathic-Parkinson-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GT","PD","BK4023","BK4585","LU1169590202.USD","LU1169589451.USD","BK4588","BK4119","GANX","BK4139","LENZ"],"gpt_icon":0},{"id":"2490585225","title":"Gain Therapeutics To Present At Biotech Showcase 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2490585225","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490585225?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:30","pubTimestamp":1733923800,"startTime":"0","endTime":"0","summary":"Presentation to Feature Lead Drug Candidate GT-02287 and Magellan Drug Discovery PlatformBETHESDA, Md., Dec.  11, 2024  (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/11/2995394/0/en/Gain-Therapeutics-To-Present-At-Biotech-Showcase-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4023","GANX","BK4119","LU1169590202.USD","BK4139","GT","PD","LU1169589451.USD","LENZ","BK4588"],"gpt_icon":0},{"id":"2489740542","title":"Gain Therapeutics Initiated at Buy by Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2489740542","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489740542?lang=en_us&edition=fundamental","pubTime":"2024-12-06 17:07","pubTimestamp":1733476020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GANX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 06, 2024 04:07 ET (09:07 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GANX","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GANX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"GANX","fiscalQuarterEnding":"2024/12","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-11-14","symbol":"GANX","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2024-08-08","symbol":"GANX","fiscalQuarterEnding":"2024/06","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2024-05-14","symbol":"GANX","fiscalQuarterEnding":"2024/03","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2024-03-26","symbol":"GANX","fiscalQuarterEnding":"2023/12","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711425600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GANX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GANX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GANX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GANX","date":"2025-05-01","current":-2.790785,"percent":0.535141,"low":-50.040751,"twenty":-5.258317,"median":-2.872692,"eighty":-2.177798,"high":-1.058647,"avg":-5.880927,"sd":8.457127,"marketCap":56963251},"quantilePoints":[{"date":"2021-03-19","current":-38.639061,"twenty":-38.005634,"median":-37.055493,"eighty":-36.105352,"marketCap":138238273},{"date":"2021-03-26","current":-42.819681,"twenty":-41.432475,"median":-39.494188,"eighty":-38.512375,"marketCap":153195201},{"date":"2021-04-01","current":-48.773897,"twenty":-46.430216,"median":-41.806197,"eighty":-38.639061,"marketCap":174497492},{"date":"2021-04-09","current":-44.276563,"twenty":-46.873615,"median":-44.308234,"eighty":-39.494188,"marketCap":158407463},{"date":"2021-04-16","current":-45.923474,"twenty":-46.430216,"median":-44.339906,"eighty":-39.937587,"marketCap":164299587},{"date":"2021-04-23","current":-38.322347,"twenty":-46.30353,"median":-44.260728,"eighty":-39.494188,"marketCap":137105172},{"date":"2021-04-30","current":-38.258688,"twenty":-45.923474,"median":-42.756338,"eighty":-38.639061,"marketCap":136877419},{"date":"2021-05-07","current":-33.25493,"twenty":-45.305882,"median":-40.95107,"eighty":-38.322347,"marketCap":118975563},{"date":"2021-05-14","current":-20.96541,"twenty":-44.65662,"median":-39.937587,"eighty":-35.471925,"marketCap":114132780},{"date":"2021-05-21","current":-23.05977,"twenty":-44.414334,"median":-38.939939,"eighty":-23.05977,"marketCap":125534182},{"date":"2021-05-28","current":-23.103402,"twenty":-44.339906,"median":-38.639061,"eighty":-22.928872,"marketCap":125771711},{"date":"2021-06-04","current":-23.212484,"twenty":-44.339906,"median":-38.322347,"eighty":-22.849069,"marketCap":126365534},{"date":"2021-06-11","current":-22.165304,"twenty":-44.289232,"median":-37.372048,"eighty":-22.470731,"marketCap":120664833},{"date":"2021-06-18","current":-19.809149,"twenty":-44.251226,"median":-35.471925,"eighty":-22.108582,"marketCap":107838256},{"date":"2021-06-25","current":-22.645261,"twenty":-43.104723,"median":-34.046714,"eighty":-21.471547,"marketCap":123277654},{"date":"2021-07-02","current":-21.83806,"twenty":-42.769007,"median":-23.539727,"eighty":-21.750795,"marketCap":118883364},{"date":"2021-07-09","current":-21.598082,"twenty":-42.186253,"median":-23.212484,"eighty":-21.471547,"marketCap":117576954},{"date":"2021-07-16","current":-20.638167,"twenty":-41.806197,"median":-23.081586,"eighty":-21.384282,"marketCap":112351311},{"date":"2021-07-23","current":-19.63462,"twenty":-40.780045,"median":-22.928872,"eighty":-21.030859,"marketCap":106888140},{"date":"2021-07-30","current":-17.452995,"twenty":-40.095943,"median":-22.740271,"eighty":-20.585808,"marketCap":95011680},{"date":"2021-08-06","current":-17.452995,"twenty":-40.000929,"median":-22.470731,"eighty":-20.267291,"marketCap":95011680},{"date":"2021-08-13","current":-11.234424,"twenty":-39.671548,"median":-22.350741,"eighty":-19.976349,"marketCap":95011680},{"date":"2021-08-20","current":-11.192295,"twenty":-39.247151,"median":-22.165304,"eighty":-19.617167,"marketCap":94655386},{"date":"2021-08-27","current":-10.925477,"twenty":-38.911435,"median":-22.056223,"eighty":-18.107483,"marketCap":92398858},{"date":"2021-09-03","current":-10.897391,"twenty":-38.702404,"median":-21.83806,"eighty":-17.452995,"marketCap":92161329},{"date":"2021-09-10","current":-12.680856,"twenty":-38.639061,"median":-21.772611,"eighty":-17.452995,"marketCap":107244433},{"date":"2021-09-17","current":-11.150166,"twenty":-38.575718,"median":-21.543541,"eighty":-12.939248,"marketCap":94299092},{"date":"2021-09-24","current":-10.433971,"twenty":-38.417361,"median":-21.401735,"eighty":-11.225998,"marketCap":88242097},{"date":"2021-10-01","current":-10.377799,"twenty":-38.322347,"median":-21.343486,"eighty":-11.183869,"marketCap":87767039},{"date":"2021-10-08","current":-9.87225,"twenty":-38.296883,"median":-20.96541,"eighty":-11.093994,"marketCap":83491513},{"date":"2021-10-15","current":-9.745863,"twenty":-37.549376,"median":-20.659983,"eighty":-10.970415,"marketCap":82422632},{"date":"2021-10-22","current":-9.689691,"twenty":-36.270043,"median":-20.507269,"eighty":-10.908625,"marketCap":81947574},{"date":"2021-10-29","current":-9.773949,"twenty":-35.756967,"median":-20.256383,"eighty":-10.852453,"marketCap":82660161},{"date":"2021-11-05","current":-10.93952,"twenty":-35.218554,"median":-19.983679,"eighty":-10.766286,"marketCap":92517623},{"date":"2021-11-12","current":-7.951084,"twenty":-34.838498,"median":-19.887252,"eighty":-10.706406,"marketCap":98007879},{"date":"2021-11-19","current":-7.97036,"twenty":-34.205071,"median":-19.63462,"eighty":-10.462057,"marketCap":98245474},{"date":"2021-11-26","current":-7.565577,"twenty":-31.316253,"median":-19.547355,"eighty":-10.422737,"marketCap":93255982},{"date":"2021-12-03","current":-6.283766,"twenty":-23.557181,"median":-18.107483,"eighty":-10.068852,"marketCap":77455924},{"date":"2021-12-10","current":-5.782607,"twenty":-23.478642,"median":-17.562076,"eighty":-9.925613,"marketCap":71278458},{"date":"2021-12-17","current":-5.68623,"twenty":-23.229937,"median":-17.452995,"eighty":-9.83293,"marketCap":70090483},{"date":"2021-12-23","current":-5.488658,"twenty":-23.212484,"median":-17.452995,"eighty":-9.745863,"marketCap":67655136},{"date":"2021-12-31","current":-5.233259,"twenty":-23.190667,"median":-17.234833,"eighty":-9.619475,"marketCap":64507004},{"date":"2022-01-07","current":-5.117607,"twenty":-23.103402,"median":-12.673834,"eighty":-9.380744,"marketCap":63081435},{"date":"2022-01-14","current":-4.510433,"twenty":-23.05977,"median":-11.234424,"eighty":-8.876301,"marketCap":55597197},{"date":"2022-01-21","current":-4.211665,"twenty":-23.024864,"median":-11.220381,"eighty":-7.966505,"marketCap":51914476},{"date":"2022-01-28","current":-3.787607,"twenty":-22.946325,"median":-11.185274,"eighty":-7.552084,"marketCap":46687389},{"date":"2022-02-04","current":-4.471883,"twenty":-22.876514,"median":-11.150166,"eighty":-6.729027,"marketCap":55122007},{"date":"2022-02-11","current":-3.999636,"twenty":-22.806003,"median":-11.058886,"eighty":-5.936809,"marketCap":49300933},{"date":"2022-02-18","current":-3.633405,"twenty":-22.709445,"median":-11.023778,"eighty":-5.67852,"marketCap":44786631},{"date":"2022-02-25","current":-3.23826,"twenty":-22.662714,"median":-10.953563,"eighty":-5.503114,"marketCap":39915936},{"date":"2022-03-04","current":-3.469564,"twenty":-22.540543,"median":-10.943031,"eighty":-5.422158,"marketCap":42767074},{"date":"2022-03-11","current":-3.286448,"twenty":-22.470731,"median":-10.897391,"eighty":-5.273737,"marketCap":40509923},{"date":"2022-03-18","current":-3.662318,"twenty":-22.418372,"median":-10.883348,"eighty":-5.16965,"marketCap":45143023},{"date":"2022-03-25","current":-3.593086,"twenty":-22.344197,"median":-10.841219,"eighty":-4.874737,"marketCap":49910145},{"date":"2022-04-01","current":-3.652971,"twenty":-22.278748,"median":-10.735896,"eighty":-4.506578,"marketCap":50741981},{"date":"2022-04-08","current":-3.610196,"twenty":-22.20021,"median":-10.700789,"eighty":-4.441042,"marketCap":50147812},{"date":"2022-04-14","current":-3.285107,"twenty":-22.165304,"median":-10.504186,"eighty":-4.344665,"marketCap":45632133},{"date":"2022-04-22","current":-2.883024,"twenty":-22.156578,"median":-10.458547,"eighty":-4.2001,"marketCap":40046950},{"date":"2022-04-29","current":-2.925799,"twenty":-22.073676,"median":-10.419928,"eighty":-4.051679,"marketCap":40641118},{"date":"2022-05-06","current":-2.934354,"twenty":-21.934052,"median":-10.075874,"eighty":-3.993854,"marketCap":40759952},{"date":"2022-05-13","current":-2.284176,"twenty":-21.86424,"median":-10.054809,"eighty":-3.882689,"marketCap":31728592},{"date":"2022-05-20","current":-2.229222,"twenty":-21.829334,"median":-9.963529,"eighty":-3.764313,"marketCap":32798095},{"date":"2022-05-27","current":-2.334221,"twenty":-21.798791,"median":-9.87225,"eighty":-3.662318,"marketCap":34342933},{"date":"2022-06-03","current":-2.826911,"twenty":-21.768248,"median":-9.830121,"eighty":-3.637318,"marketCap":41591788},{"date":"2022-06-10","current":-2.915757,"twenty":-21.720252,"median":-9.759906,"eighty":-3.577687,"marketCap":42898958},{"date":"2022-06-17","current":-2.939988,"twenty":-21.576266,"median":-9.703734,"eighty":-3.516424,"marketCap":43255459},{"date":"2022-06-24","current":-3.166141,"twenty":-21.489,"median":-9.619475,"eighty":-3.469564,"marketCap":46582802},{"date":"2022-07-01","current":-2.802681,"twenty":-21.445368,"median":-9.486066,"eighty":-3.387767,"marketCap":41235286},{"date":"2022-07-08","current":-3.06518,"twenty":-21.410462,"median":-9.338615,"eighty":-3.353912,"marketCap":45097381},{"date":"2022-07-15","current":-3.238833,"twenty":-21.366829,"median":-8.905214,"eighty":-3.305907,"marketCap":47652305},{"date":"2022-07-22","current":-3.392294,"twenty":-21.352169,"median":-8.346229,"eighty":-3.283396,"marketCap":49910145},{"date":"2022-07-29","current":-3.214602,"twenty":-21.339167,"median":-7.951084,"eighty":-3.269708,"marketCap":47295804},{"date":"2022-08-05","current":-3.238833,"twenty":-21.126851,"median":-7.666773,"eighty":-3.238718,"marketCap":47652305},{"date":"2022-08-12","current":-3.036412,"twenty":-20.987226,"median":-7.343911,"eighty":-3.217833,"marketCap":49315977},{"date":"2022-08-19","current":-2.677896,"twenty":-20.947957,"median":-6.645179,"eighty":-3.203421,"marketCap":43493126},{"date":"2022-08-26","current":-2.633996,"twenty":-20.734158,"median":-6.197027,"eighty":-3.16291,"marketCap":42780124},{"date":"2022-09-02","current":-2.670579,"twenty":-20.646893,"median":-5.777788,"eighty":-3.140295,"marketCap":43374293},{"date":"2022-09-09","current":-2.838862,"twenty":-20.559628,"median":-5.691049,"eighty":-3.098295,"marketCap":46107467},{"date":"2022-09-16","current":-2.773013,"twenty":-20.507269,"median":-5.512752,"eighty":-3.060757,"marketCap":45037964},{"date":"2022-09-23","current":-2.436446,"twenty":-20.45491,"median":-5.495886,"eighty":-3.036412,"marketCap":39571615},{"date":"2022-09-30","current":-2.38523,"twenty":-20.354555,"median":-5.445288,"eighty":-3.001607,"marketCap":38739779},{"date":"2022-10-07","current":-2.377913,"twenty":-20.245474,"median":-5.334454,"eighty":-2.954271,"marketCap":38620946},{"date":"2022-10-14","current":-2.304747,"twenty":-20.123304,"median":-5.262172,"eighty":-2.937734,"marketCap":37432609},{"date":"2022-10-21","current":-2.268163,"twenty":-20.018585,"median":-5.218803,"eighty":-2.923218,"marketCap":36838440},{"date":"2022-10-28","current":-2.436446,"twenty":-19.983679,"median":-5.107969,"eighty":-2.904662,"marketCap":39571615},{"date":"2022-11-04","current":-2.23158,"twenty":-19.972684,"median":-4.862208,"eighty":-2.887257,"marketCap":36244272},{"date":"2022-11-11","current":-2.363977,"twenty":-19.871631,"median":-4.683911,"eighty":-2.847642,"marketCap":38145611},{"date":"2022-11-18","current":-2.271553,"twenty":-19.704432,"median":-4.491158,"eighty":-2.799594,"marketCap":36654248},{"date":"2022-11-25","current":-2.282968,"twenty":-19.63462,"median":-4.471883,"eighty":-2.747199,"marketCap":36838440},{"date":"2022-12-02","current":-2.38607,"twenty":-19.617167,"median":-4.385143,"eighty":-2.673506,"marketCap":38502112},{"date":"2022-12-09","current":-2.297697,"twenty":-19.573534,"median":-4.303223,"eighty":-2.657297,"marketCap":37076108},{"date":"2022-12-16","current":-2.194595,"twenty":-19.451363,"median":-4.211665,"eighty":-2.615297,"marketCap":35412436},{"date":"2022-12-23","current":-2.31979,"twenty":-18.827419,"median":-4.134564,"eighty":-2.563756,"marketCap":37432609},{"date":"2022-12-30","current":-2.305061,"twenty":-18.107483,"median":-4.057462,"eighty":-2.511076,"marketCap":37194941},{"date":"2023-01-06","current":-2.38607,"twenty":-18.107483,"median":-4.009274,"eighty":-2.45108,"marketCap":38502112},{"date":"2023-01-13","current":-2.85754,"twenty":-17.88932,"median":-3.989999,"eighty":-2.45108,"marketCap":46109844},{"date":"2023-01-20","current":-2.813206,"twenty":-17.627525,"median":-3.901065,"eighty":-2.474493,"marketCap":45394465},{"date":"2023-01-27","current":-2.997316,"twenty":-17.474811,"median":-3.865235,"eighty":-2.491936,"marketCap":48365307},{"date":"2023-02-03","current":-2.908943,"twenty":-17.452995,"median":-3.772741,"eighty":-2.506657,"marketCap":46939303},{"date":"2023-02-10","current":-3.019409,"twenty":-17.452995,"median":-3.7346,"eighty":-2.515467,"marketCap":48721808},{"date":"2023-02-17","current":-3.034138,"twenty":-17.452995,"median":-3.662318,"eighty":-2.522783,"marketCap":48959476},{"date":"2023-02-24","current":-3.093053,"twenty":-17.452995,"median":-3.652971,"eighty":-2.542969,"marketCap":49910145},{"date":"2023-03-03","current":-2.901579,"twenty":-17.452995,"median":-3.601641,"eighty":-2.558678,"marketCap":46820469},{"date":"2023-03-10","current":-2.70274,"twenty":-17.322098,"median":-3.575976,"eighty":-2.56522,"marketCap":43611960},{"date":"2023-03-17","current":-3.402359,"twenty":-14.890034,"median":-3.537028,"eighty":-2.572536,"marketCap":54901160},{"date":"2023-03-24","current":-3.31018,"twenty":-12.939248,"median":-3.556303,"eighty":-2.584243,"marketCap":58228503},{"date":"2023-03-31","current":-3.256136,"twenty":-12.67243,"median":-3.507537,"eighty":-2.601339,"marketCap":57277833},{"date":"2023-04-06","current":-3.161559,"twenty":-12.363483,"median":-3.484273,"eighty":-2.615297,"marketCap":55614162},{"date":"2023-04-14","current":-3.222359,"twenty":-11.773676,"median":-3.422611,"eighty":-2.625327,"marketCap":56683665},{"date":"2023-04-21","current":-3.377734,"twenty":-11.231615,"median":-3.396322,"eighty":-2.628142,"marketCap":59416840},{"date":"2023-04-28","current":-3.343957,"twenty":-11.220381,"median":-3.394308,"eighty":-2.638656,"marketCap":58822671},{"date":"2023-05-05","current":-3.559408,"twenty":-11.220381,"median":-3.399341,"eighty":-2.657297,"marketCap":62612613},{"date":"2023-05-12","current":-3.559408,"twenty":-11.192295,"median":-3.469564,"eighty":-2.657297,"marketCap":62612613},{"date":"2023-05-19","current":-2.987047,"twenty":-11.192295,"median":-3.399341,"eighty":-2.660595,"marketCap":58114231},{"date":"2023-05-26","current":-2.921345,"twenty":-11.178252,"median":-3.392294,"eighty":-2.665374,"marketCap":56835980},{"date":"2023-06-01","current":-2.921345,"twenty":-11.172635,"median":-3.392294,"eighty":-2.665592,"marketCap":56835980},{"date":"2023-06-09","current":-3.041748,"twenty":-11.158592,"median":-3.387767,"eighty":-2.667782,"marketCap":59178460},{"date":"2023-06-16","current":-3.086107,"twenty":-11.138932,"median":-3.367601,"eighty":-2.672042,"marketCap":60041480},{"date":"2023-06-23","current":-2.946693,"twenty":-11.093994,"median":-3.353912,"eighty":-2.677896,"marketCap":57329133},{"date":"2023-06-30","current":-2.851638,"twenty":-11.093994,"median":-3.353912,"eighty":-2.692802,"marketCap":55479807},{"date":"2023-07-07","current":-2.813617,"twenty":-11.065908,"median":-3.343957,"eighty":-2.706414,"marketCap":54740076},{"date":"2023-07-14","current":-2.851638,"twenty":-11.023778,"median":-3.343832,"eighty":-2.711925,"marketCap":55479807},{"date":"2023-07-21","current":-2.788269,"twenty":-11.023778,"median":-3.327679,"eighty":-2.71548,"marketCap":54246922},{"date":"2023-07-28","current":-2.414387,"twenty":-11.023778,"median":-3.315049,"eighty":-2.677896,"marketCap":46972903},{"date":"2023-08-04","current":-2.433398,"twenty":-10.995692,"median":-3.296669,"eighty":-2.660595,"marketCap":47342768},{"date":"2023-08-11","current":-2.249626,"twenty":-10.953563,"median":-3.284133,"eighty":-2.629844,"marketCap":43767403},{"date":"2023-08-18","current":-2.141714,"twenty":-10.953563,"median":-3.276552,"eighty":-2.590096,"marketCap":47241849},{"date":"2023-08-25","current":-2.066869,"twenty":-10.946542,"median":-3.256136,"eighty":-2.555451,"marketCap":45590924},{"date":"2023-09-01","current":-1.905665,"twenty":-10.93952,"median":-3.255071,"eighty":-2.522116,"marketCap":42035086},{"date":"2023-09-08","current":-2.101413,"twenty":-10.928286,"median":-3.242333,"eighty":-2.506657,"marketCap":46352890},{"date":"2023-09-15","current":-2.118685,"twenty":-10.903008,"median":-3.238546,"eighty":-2.45108,"marketCap":46733872},{"date":"2023-09-22","current":-1.859607,"twenty":-10.897391,"median":-3.237064,"eighty":-2.443763,"marketCap":41019133},{"date":"2023-09-29","current":-1.836577,"twenty":-10.891774,"median":-3.233315,"eighty":-2.434617,"marketCap":40511156},{"date":"2023-10-06","current":-1.853849,"twenty":-10.883348,"median":-3.228622,"eighty":-2.422892,"marketCap":40892138},{"date":"2023-10-13","current":-1.905665,"twenty":-10.883348,"median":-3.216622,"eighty":-2.408163,"marketCap":42035086},{"date":"2023-10-19","current":-1.819305,"twenty":-10.877731,"median":-3.214602,"eighty":-2.407413,"marketCap":40130173},{"date":"2023-10-27","current":-1.689766,"twenty":-10.872114,"median":-3.211725,"eighty":-2.400612,"marketCap":37272803},{"date":"2023-11-03","current":-1.571742,"twenty":-10.846836,"median":-3.206525,"eighty":-2.394988,"marketCap":34669422},{"date":"2023-11-10","current":-1.537198,"twenty":-10.809313,"median":-3.201846,"eighty":-2.38607,"marketCap":33907456},{"date":"2023-11-17","current":-1.577567,"twenty":-10.754602,"median":-3.188379,"eighty":-2.377913,"marketCap":35050404},{"date":"2023-11-24","current":-1.470271,"twenty":-10.734492,"median":-3.181826,"eighty":-2.377294,"marketCap":32666513},{"date":"2023-12-01","current":-1.456658,"twenty":-10.720449,"median":-3.170608,"eighty":-2.363863,"marketCap":32364046},{"date":"2023-12-08","current":-1.715317,"twenty":-10.706406,"median":-3.161559,"eighty":-2.334519,"marketCap":38110932},{"date":"2023-12-15","current":-1.72893,"twenty":-10.675512,"median":-3.1529,"eighty":-2.326697,"marketCap":38413400},{"date":"2023-12-22","current":-1.701703,"twenty":-10.565976,"median":-3.149476,"eighty":-2.316598,"marketCap":37808465},{"date":"2023-12-29","current":-2.001203,"twenty":-10.49576,"median":-3.142591,"eighty":-2.30481,"marketCap":44462754},{"date":"2024-01-05","current":-2.653959,"twenty":-10.470483,"median":-3.14191,"eighty":-2.304998,"marketCap":58965699},{"date":"2024-01-12","current":-2.478972,"twenty":-10.462057,"median":-3.131855,"eighty":-2.310953,"marketCap":55077851},{"date":"2024-01-19","current":-2.449808,"twenty":-10.457844,"median":-3.127002,"eighty":-2.316598,"marketCap":54429876},{"date":"2024-01-26","current":-2.584693,"twenty":-10.442397,"median":-3.117791,"eighty":-2.319626,"marketCap":57426759},{"date":"2024-02-02","current":-2.748743,"twenty":-10.425545,"median":-3.101526,"eighty":-2.323934,"marketCap":61071617},{"date":"2024-02-09","current":-3.52889,"twenty":-10.394651,"median":-3.114271,"eighty":-2.326697,"marketCap":78404941},{"date":"2024-02-16","current":-3.499726,"twenty":-10.200857,"median":-3.12332,"eighty":-2.326697,"marketCap":77756966},{"date":"2024-02-23","current":-3.237246,"twenty":-10.077278,"median":-3.129876,"eighty":-2.329623,"marketCap":71925193},{"date":"2024-03-01","current":-3.273702,"twenty":-10.068852,"median":-3.141293,"eighty":-2.334096,"marketCap":72735162},{"date":"2024-03-08","current":-3.353904,"twenty":-10.063235,"median":-3.142591,"eighty":-2.33434,"marketCap":74517092},{"date":"2024-03-15","current":-3.120589,"twenty":-10.049192,"median":-3.149476,"eighty":-2.334519,"marketCap":69333295},{"date":"2024-03-22","current":-3.186209,"twenty":-10.035149,"median":-3.146375,"eighty":-2.337465,"marketCap":70791238},{"date":"2024-03-28","current":-2.71694,"twenty":-10.001446,"median":-3.14191,"eighty":-2.342324,"marketCap":60499514},{"date":"2024-04-05","current":-2.60768,"twenty":-9.897527,"median":-3.133833,"eighty":-2.344999,"marketCap":58066558},{"date":"2024-04-12","current":-2.447431,"twenty":-9.883484,"median":-3.128878,"eighty":-2.351656,"marketCap":54498222},{"date":"2024-04-19","current":-2.294467,"twenty":-9.866633,"median":-3.122511,"eighty":-2.334519,"marketCap":51092083},{"date":"2024-04-26","current":-2.236195,"twenty":-9.841355,"median":-3.116031,"eighty":-2.32816,"marketCap":49794506},{"date":"2024-05-03","current":-2.375312,"twenty":-9.824504,"median":-3.101526,"eighty":-2.334055,"marketCap":52892298},{"date":"2024-05-10","current":-2.059144,"twenty":-9.796418,"median":-3.099567,"eighty":-2.326697,"marketCap":45852026},{"date":"2024-05-17","current":-2.296581,"twenty":-9.768332,"median":-3.093281,"eighty":-2.319462,"marketCap":48559823},{"date":"2024-05-24","current":-2.091682,"twenty":-9.745863,"median":-3.086107,"eighty":-2.310851,"marketCap":44227348},{"date":"2024-05-31","current":-2.142907,"twenty":-9.745863,"median":-3.086075,"eighty":-2.304747,"marketCap":45310467},{"date":"2024-06-07","current":-1.99777,"twenty":-9.703734,"median":-3.084057,"eighty":-2.301286,"marketCap":42241630},{"date":"2024-06-14","current":-1.613583,"twenty":-9.6925,"median":-3.07977,"eighty":-2.296158,"marketCap":34118240},{"date":"2024-06-21","current":-1.109872,"twenty":-9.647561,"median":-3.073433,"eighty":-2.287738,"marketCap":23467572},{"date":"2024-06-28","current":-1.067185,"twenty":-9.619475,"median":-3.06518,"eighty":-2.282968,"marketCap":22564973},{"date":"2024-07-05","current":-1.380767,"twenty":-9.585772,"median":-3.054123,"eighty":-2.281358,"marketCap":29195490},{"date":"2024-07-12","current":-1.618831,"twenty":-9.50994,"median":-3.043368,"eighty":-2.269333,"marketCap":34229195},{"date":"2024-07-15","current":-1.642637,"twenty":-9.493088,"median":-3.041748,"eighty":-2.268239,"marketCap":34732565},{"date":"2024-08-02","current":-1.261736,"twenty":-9.490279,"median":-3.041748,"eighty":-2.268178,"marketCap":26678637},{"date":"2024-08-09","current":-1.151036,"twenty":-9.459385,"median":-3.036412,"eighty":-2.251312,"marketCap":24337964},{"date":"2024-08-16","current":-1.454136,"twenty":-9.363892,"median":-3.035004,"eighty":-2.246146,"marketCap":31408615},{"date":"2024-08-23","current":-1.548714,"twenty":-9.276826,"median":-3.026774,"eighty":-2.240189,"marketCap":33451452},{"date":"2024-08-30","current":-1.26498,"twenty":-9.139591,"median":-3.019409,"eighty":-2.232503,"marketCap":27322942},{"date":"2024-09-06","current":-1.282713,"twenty":-8.905214,"median":-3.012045,"eighty":-2.224263,"marketCap":27705974},{"date":"2024-09-13","current":-1.73787,"twenty":-8.876301,"median":-3.002793,"eighty":-2.209324,"marketCap":37537126},{"date":"2024-09-20","current":-1.767425,"twenty":-8.442606,"median":-2.996921,"eighty":-2.187231,"marketCap":38175512},{"date":"2024-09-27","current":-2.181204,"twenty":-8.249852,"median":-2.987047,"eighty":-2.173047,"marketCap":47112923},{"date":"2024-10-04","current":-2.033426,"twenty":-7.97036,"median":-2.960339,"eighty":-2.17264,"marketCap":43920991},{"date":"2024-10-11","current":-2.328982,"twenty":-7.951084,"median":-2.951464,"eighty":-2.17264,"marketCap":50304856},{"date":"2024-10-18","current":-3.274761,"twenty":-7.873983,"median":-2.949765,"eighty":-2.172683,"marketCap":70733224},{"date":"2024-10-25","current":-3.168361,"twenty":-7.767968,"median":-2.960185,"eighty":-2.172683,"marketCap":68435032},{"date":"2024-10-31","current":-2.577249,"twenty":-7.606055,"median":-2.960494,"eighty":-2.172974,"marketCap":55667302},{"date":"2024-11-08","current":-2.63636,"twenty":-7.511606,"median":-2.953803,"eighty":-2.176255,"marketCap":56944075},{"date":"2024-11-15","current":-2.062981,"twenty":-7.374751,"median":-2.946693,"eighty":-2.176255,"marketCap":44559377},{"date":"2024-11-22","current":-1.93605,"twenty":-7.050925,"median":-2.939988,"eighty":-2.172674,"marketCap":41367445},{"date":"2024-11-29","current":-2.309018,"twenty":-6.862027,"median":-2.934187,"eighty":-2.172585,"marketCap":49336626},{"date":"2024-12-06","current":-2.122807,"twenty":-6.61723,"median":-2.926662,"eighty":-2.172486,"marketCap":45357866},{"date":"2024-12-13","current":-2.07315,"twenty":-6.372433,"median":-2.923672,"eighty":-2.164769,"marketCap":44296863},{"date":"2024-12-20","current":-1.94901,"twenty":-6.231723,"median":-2.921345,"eighty":-2.145744,"marketCap":41644356},{"date":"2024-12-27","current":-1.986252,"twenty":-6.10836,"median":-2.919346,"eighty":-2.141714,"marketCap":42440108},{"date":"2025-01-03","current":-2.880065,"twenty":-5.936809,"median":-2.915757,"eighty":-2.141953,"marketCap":61538157},{"date":"2025-01-10","current":-3.029034,"twenty":-5.782607,"median":-2.916308,"eighty":-2.142907,"marketCap":64721165},{"date":"2025-01-17","current":-2.942135,"twenty":-5.772969,"median":-2.915757,"eighty":-2.142907,"marketCap":62864411},{"date":"2025-01-24","current":-2.768338,"twenty":-5.711288,"median":-2.909045,"eighty":-2.146689,"marketCap":59150901},{"date":"2025-01-31","current":-2.731096,"twenty":-5.688158,"median":-2.908671,"eighty":-2.148289,"marketCap":58355149},{"date":"2025-02-07","current":-3.277315,"twenty":-5.655389,"median":-2.908176,"eighty":-2.151009,"marketCap":70026179},{"date":"2025-02-14","current":-3.178003,"twenty":-5.539737,"median":-2.908943,"eighty":-2.152913,"marketCap":67904174},{"date":"2025-02-21","current":-2.904893,"twenty":-5.506969,"median":-2.909147,"eighty":-2.164769,"marketCap":62068659},{"date":"2025-02-28","current":-2.358674,"twenty":-5.503114,"median":-2.908807,"eighty":-2.172486,"marketCap":50397629},{"date":"2025-03-07","current":-2.234533,"twenty":-5.49444,"median":-2.906324,"eighty":-2.172502,"marketCap":47745122},{"date":"2025-03-14","current":-2.731096,"twenty":-5.479984,"median":-2.901579,"eighty":-2.172585,"marketCap":58355149},{"date":"2025-03-21","current":-2.842823,"twenty":-5.456853,"median":-2.901579,"eighty":-2.172666,"marketCap":60742405},{"date":"2025-03-28","current":-2.569713,"twenty":-5.410592,"median":-2.900856,"eighty":-2.172683,"marketCap":54906890},{"date":"2025-04-04","current":-2.436832,"twenty":-5.387462,"median":-2.891579,"eighty":-2.172901,"marketCap":49738644},{"date":"2025-04-11","current":-2.150947,"twenty":-5.323853,"median":-2.88966,"eighty":-2.172683,"marketCap":43903384},{"date":"2025-04-17","current":-2.368764,"twenty":-5.281447,"median":-2.882893,"eighty":-2.172829,"marketCap":48349296},{"date":"2025-04-25","current":-2.559354,"twenty":-5.273737,"median":-2.880065,"eighty":-2.174651,"marketCap":52239469},{"date":"2025-05-01","current":-2.790785,"twenty":-5.258317,"median":-2.872692,"eighty":-2.177798,"marketCap":56963251}],"updateTime":1746225604684}}}